Prevention measures of family members to exposure antineoplastic drugs based on the evidence
Project/Area Number |
26671014
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Gerontological nursing
|
Research Institution | Hokkaido University |
Principal Investigator |
YUKI MICHIKO 北海道大学, 保健科学研究院, 教授 (20276661)
|
Project Period (FY) |
2014-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
Fiscal Year 2015: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2014: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
Keywords | 抗がん薬 / 曝露 / 外来化学療法 / がん患者 / 家族 / 自宅 / 抗がん剤曝露 / 外来 / 化学療法 / 抗がん剤 |
Outline of Final Research Achievements |
The aim of this study was to confirm if the families of patients who received chemotherapy via oral administration or intravenous injection of CPA were exposed to CPA. This was done by measurering the amount of CPA excreted in the urine for approximately 3days after CPA therapy. Results showed that the families of patients who received outpatient CPA chemothrapy were exposed to the patient drug, presumably via residue in the patients excrement and other body fluids. This indicated the need for anti- cancer drug exposure prevention in the families of patients at home settings.
|
Report
(3 results)
Research Products
(1 results)